Featured
Measles Cases Surge, Three States Report Fatalities
Growth Charts Nov 7, 2026
Child Vaccines Nov 6, 2026
Growth Charts Nov 5, 2026
Half of long COVID patients see significant improvement within three years, with over a quarter...
Breast bruises may not always be harmless, as they can sometimes be a sign of...
A UCSF study links autoantibodies to preterm birth risk, identifying antibodies that may trigger early...
Read our latest Germ Control articles.
Cefiderocol exhibits improved in vitro activity against multidrug-resistant Gram-negative pathogens at IDWeek 2026, with MICs...
Living with polycythemia vera requires balance and paying attention to body cues to avoid overexertion.
polycythemia vera treatment path explained: doctors detail first-line therapeutic phlebotomy and medication timing to help...
The USS Abraham Lincoln carrier strike group reported eight suicide attempts during a 10-month deployment, revealing mental health struggles among personnel.
The USS Abraham Lincoln carrier strike group reported eight suicide attempts during a 10-month deployment, revealing mental health struggles among...
AI coding dispute where insurers blame rising costs on AI tools flagging complex diagnoses, while hospitals cite sicker patients.
One measles-related death has occurred in the U.S. this year, but the CDC has not disclosed the identity or location...
Addressing social determinants can improve stroke prevention in underserved communities, reducing disparities and saving lives.
Acupuncture may improve Parkinson's disease symptoms, including motor function and quality of life, according to a new study.
Neurologists discuss cluster headache treatments and emerging approaches for chronic cluster headache patients.
New treatments emerge for Alzheimer's agitation, moving beyond off-label drug use with modest benefits.
Denali Therapeutics halted the SAR443820 trial after a phase 2 study failed to slow functional decline in adults with ALS,...
Genetic testing aids epilepsy diagnosis in children with seizures and developmental delays, offering new insights into disease origins.
Expert discusses TDP-43 role in ALS research, a protein present in 97% of ALS patients, to make ALS livable.